[1]
Hind A. Alnajashi and Foziah Alshamrani, “Progressive Multifocal Leukoencephalopathy Risk Mitigation: A Focus on Approved Immunomodulatory Drugs for Multiple Sclerosis Treatment”, JKAU Med Sci, vol. 27, no. 2, pp. 33–44, Dec. 2020.